Stelara® (Ustekinumab) treatment in Patients with Pyoderma gangrenosum
Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-placebo controlled pilot study with 10 patients. - SPG-Trial Open-label Trial of Stelara® (Ustekinumab) In Patients with Pyoderma gangrenosum – an open, non-plac ...
Patients with a clinical diagnosis of Pyoderma gangrenosum MedDRA version: 14.1;Level: LLT;Classification code 10037634;Term: Pyoderma gangenosum;System Organ Class: 10040785 - Skin and subcutaneous tissue disorders;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] Patients with a clinical diagnosis of Pyoderma gangrenosum MedDRA version: 14.1;Level: LLT;Classific ...